DUT is a competitive inhibitor of type I and type II 5-α-reductase and has been globally approved under the brand name Avodart® soft capsule (GlaxoSmithKline) for the treatment of benign prostatic hyperplasia and androgenetic alopecia [15,16,17]. Here, SGCG is linked to benign prostatic hyperplasia.